Articles tagged with Bronchitis
A new study found that doctors' judgments alone are insufficient to accurately diagnose cases of pneumonia. The researchers analyzed 2,810 patients and concluded that a majority of radiographically confirmed cases were not identified through initial assessments.
A study by Dr. Mark Ebell found that patients expect to cough for 7-9 days, while the actual duration is closer to 18 days. This mismatch may contribute to over-prescription of antibiotics, which can lead to antibiotic resistance and increased healthcare costs.
Researchers found that cigarette smoke suppresses protein Bik, leading to sustained mucus cell growth and airway obstruction. The study's findings suggest a potential therapeutic target for reducing excess mucus secretion in chronic bronchitis patients.
A study found that combining nebulized formoterol fumarate with tiotropium significantly improved COPD symptoms, including shortness of breath and chest tightness, in patients. The treatment also showed enhanced control of COPD symptoms, with decreased use of albuterol rescue medication.
The US Food and Drug Administration is considering new rules that would require new antibiotics to be clinically superior to existing drugs, rather than non-inferior. This change could discourage pharmaceutical companies from developing new antibiotics for common infections.
A study found that efficient primary care can prevent over 50% of hospitalizations caused by diabetic ketoacidosis, digestive haemorrhage, and chronic bronchitis in older patients. Effective management of these conditions could also reduce the risk of hospitalization for other health problems.
Researchers found that genetic factors account for 40% of the risk for chronic bronchitis, but also identified a link between genetic predisposition to smoking and the development of the disease. The study suggests that smoking remains a primary risk factor for chronic bronchitis, regardless of genetic background.
Researchers found that frequent snoring is associated with a higher risk of developing chronic bronchitis, which involves inflammation of the lower airways. Individuals who snored six times or more per week were up to 68% more likely to develop bronchitis than those who never snored.
The FDA-approved Perforomist Inhalation Solution is a long-acting bronchodilator that improves the quality of life for COPD patients. The solution was shown to be effective in treating chronic obstructive pulmonary disease (COPD) symptoms and improving lung function.
A Mediterranean diet rich in fruits, vegetables, and whole grains is associated with a 50% lower risk of developing chronic obstructive pulmonary disease (COPD). The study tracked the health of over 43,000 US men, finding that those who followed a Western diet were more than four times as likely to develop COPD.
Researchers at Virginia Commonwealth University conclude that antibiotics are not effective in treating short-term bronchitis, which is usually caused by viral infections. The study suggests that physicians should inform patients that there is no data to support the use of antibiotics for this condition, saving them from potential side...
Exposure to environmental tobacco smoke (ETS) was strongly associated with the development of respiratory symptoms, including cough, wheeze, and dyspnea, in healthy never-smokers. The study found a particular risk among individuals with bronchial hyper-reactivity who were persistently exposed to ETS.
A study of 149 smokers found that those with extensive facial wrinkles were five times more likely to develop COPD, with triple the risk of severe emphysema. The researchers suggest that facial wrinkling may be a common susceptibility factor for smoking-related lung disease.
Researchers studied four groups of apprentices, finding that machinists had the worst sensitivity to lung irritants and were more likely to develop asthma and bronchitis. Early occupational exposure to chemicals such as isosyanates may be a risk factor for developing lung disease.
A study found that Chronic Obstructive Pulmonary Disease (COPD) affects around 1,000 people in Latin American cities. The disease prevalence varies greatly between cities, with rates ranging from 7.8% to 20%. Altitude is a key factor contributing to the high COPD rates in Latin America.
Researchers discovered six genes linked to chronic lung rejection, potentially leading to an early genetic test and targeted treatments. The study's findings could improve lung transplant patient survival by detecting scarring earlier.
A survey of 606 recurrent chronic sinusitis or bronchitis sufferers found that nearly a quarter reported missing three or more days of work due to their illness. Antibiotics were associated with faster recovery times compared to over-the-counter medicines, particularly for symptoms lasting one to two days.
Providing cough and cold care kits to patients with upper respiratory illness or acute bronchitis significantly reduces unnecessary antibiotic use. The kits contain pain relievers, decongestant, and other over-the-counter medications to treat symptoms.
A new study links workplace exposure to chronic obstructive pulmonary disease (COPD), affecting three to five million people in the US. The research suggests that controlling hazardous exposures can play a significant role in reducing COPD cases.
A study published in The Lancet found that azithromycin, a commonly prescribed antibiotic, is no more effective than low-dose vitamin C in treating acute bronchitis. Patients who received azithromycin had similar improvements in quality-of-life scores as those who received vitamin C.
A comparative study found Factive eradicated H. influenzae after one day, while Biaxin took seven days. The results showed Factive's superior efficacy in treating chronic bronchitis airway infections.
A six-month study confirms that antibiotic choice significantly impacts long-term patient outcomes for acute infections, with gemifloxacin reducing hospitalizations and recurrences of chronic bronchitis. The study found a 30% lower rate of recurrence in patients treated with gemifloxacin compared to clarithromycin.